Treatments & Interventions
Interferon alfacon-1
substance
Interferon gamma-1b
substance
Interferon alfa-2a
substance
Interferon alfa-2b
substance
Ribavirin
substance
Peginterferon alfa-2b
substance
Peginterferon alfa-2a
substance
Boceprevir
substance
Telaprevir
substance
Simeprevir
substance
Sofosbuvir
substance
Ledipasvir
substance
Daclatasvir
substance
Ombitasvir
substance
Dasabuvir
substance
Paritaprevir
substance
Asunaprevir
substance
Grazoprevir
substance
Elbasvir
substance
Velpatasvir
substance
Clinical Trials
Recent Trials
Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Model Towards Elimination of Hepatitis C Infection in Egypt: Feasibility and Effectiveness in 73 Villages
A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C
A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C
Research Evidence
Peer-reviewed studies linked via MeSH term "Hepatitis C, Chronic" from the MEDLINE/PubMed database.
Research data from MEDLINE/PubMed
Related Conditions
Quick Facts
- SNOMED CT
- 128302006
- UMLS CUI
- C0524910
- Fully Specified Name
- Chronic hepatitis C (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 20
- Clinical Trials
- 102
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.